Page 341 - Programma definitivo

SESSIONI DI COMUNICAZIONE
ANMCO2024 SABATO 18 maggio 2024

8.00-9.00 - SALA del TEMPIO

C83 - PRIMARY RESULTS FROM APOLLO-B OPEN-LABEL EXTENSION STUDY
OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS
S. Longhi,-M. Mauer,-J. Berk,-M. Hanna,-J. Gillmore,-P. Vellosa-schwartzmann,-O. Lairez,-
M. Hatano,-H. Cho,-P. Van Der Meer,-M. White,-E. Yureneva,-M. Sweetser,-P. Jay,-J. Vest,-
M. Fontana
Ospedale Policlinico S. Orsola-malpighi, Bologna; Columbia University Medical Center, New York; Boston University
School Of Medicine, Boston; Department Of Cardiovascular Medicine, Cleveland Clinic, Cleveland; Ucl Medical School,
Royal Free Hospital, National Amyloidosis Centre, London; Unimed Hospital, Ribeirão Preto, São Paulo, Brazil; 5advanced
Research Centre, Caped, Ribeirão Preto, San Paolo; Hôpital De Rangueil, Toulouse; The University Of Tokyo Hospital, Tokyo;
Seoul National University Hospital, Seoul; Universitair Medisch Centrum Groningen, University Of Groningen, Groningen;
Alnylam Pharmaceuticals, Cambridge; Alnylam Pharmaceuticals, Cambridge; Alnylam Pharmaceuticals, Cambridge; Alnylam
Pharmaceuticals, Cambridge; Alnylam Pharmaceuticals, Cambridge; Division Of Medicine, University College London, Royal
Free Hospital, London

C84 - ECG SCREENING FOR CARDIOVASCULAR DISEASE IN ENDURANCE ATHLETES
OVER 40
P. Liporace,-D. Ricciardi,-E. Crispino,-F. Marchi,-M. D’Amore,-G. Loiacono,-L. Sanasi,-
E. Sposito,-E. Italiano,-F. Picarelli,-V. Calabrese,-F. Gioia,-F. Grigioni,-G. Ussia
Campus Biomedico, Roma; Campus Biomedico, Roma; Campus Biomedico, Roma; Policlinico Campus Bio-medico, Roma;
Policlinico Campus Bio-medico, Roma; Policlinico Campus Bio-medico, Roma; Policlinico Campus Bio-medico, Roma; Policlinico
Campus Bio-medico, Roma; Policlinico Campus Bio-medico, Roma; Policlinico Campus Bio-medico, Roma; Policlinico Campus Bio-
medico, Roma; Policlinico Campus Bio-medico, Roma; Campus Biomedico, Roma; Policlinico Tor Vergata, Roma

Sabato 18 MAGGIO 2024

341